$43.28
arrow_drop_down1.72%Key Stats | |
---|---|
Open | $44.31 |
Prev. Close | $44.04 |
EPS | -6.50 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 42.97 | 44.56 |
52 Week Range | 19.79 | 50.35 |
Ratios | |
---|---|
EPS | -6.50 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Agios to Present at the 2024 Cantor Global Healthcare Conference on September 18, 2024
Agios to Receive $1.1 Billion in Milestone Payments Following FDA Approval of Vorasidenib
Agios Pharmaceuticals (AGIO) Surges 6.5%: Is This an Indication of Further Gains?
Agios Presents Positive Results from Phase 3 ENERGIZE Study of Mitapivat in Non-Transfusion-Dependent Thalassemia in Plenary Session at the European Hematology Association 2024 Hybrid Congress
Prestige Consumer Healthcare (PBH) Down 0.4% Since Last Earnings Report: Can It Rebound?
Agios (AGIO) Up 21% on Upbeat Data From 2nd Thalassemia Study